4P

LAVA Therapeutics NVFRA LAVA Therapeutics Stock Report

Last reporting period 30 Jun, 2024

Updated 04 Nov, 2024

Last price

Market cap $B

0.044

Micro

Exchange

XFRA - Deutsche Boerse AG

View Section: Price ratios

LAVA Therapeutics Statements

4P

Data from LAVA Therapeutics`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

USD - US dollar

Last reporting period:

30 Jun, 2024

Next reporting period:

28 Sep, 2024

Report frequency:

Quarterly

Earnings release date:

20 Aug, 2024

Expected release date:

13 Nov, 2024

LAVA Therapeutics Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

USD (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2024-06-30
%

-100 %

100

0

-100 %

0

6.336

0

3.025

0

9.361

4.7 %

0

-9.361

-379.6 %

0

1.15

0

0

-8.211

-1596.5 %

0

0.085

0

-8.296

-1400.2 %

0

-0.309

26.822

2024-03-31
%

6.992

1880.7 %

100

0

6.992

3413.6 %

100

6.009

85.9

2.935

42

8.944

58.6 %

127.9

-1.952

64.1 %

-27.9

1.468

21

0

-0.484

92.5 %

-6.9

0.069

1

-0.553

91.5 %

-7.9

-0.021

26.794

2023-12-31
%

0.353

566 %

100

0.154

43.6

0.199

362.8 %

56.4

3.36

951.8

2.281

646.2

5.641

-47.6 %

1598

-5.442

49.3 %

-1541.6

-0.995

-281.9

0

-6.437

26.7 %

-1823.5

0.061

17.3

-6.498

26.5 %

-1840.8

-0.232

28.063

2023-09-30
%

0.053

-99 %

100

0.01

18.9

0.043

-98.4 %

81.1

7.912

14928.3

2.858

5392.5

10.77

-33.9 %

20320.8

-10.727

20.8 %

-20239.6

1.941

3662.3

0

-8.786

30.3 %

-16577.4

0.05

94.3

-8.836

30.4 %

-16671.7

-0.336

26.289

2023-06-30
%

5.14

321.3 %

100

2.39

46.5

2.75

848.3 %

53.5

12.6

245.1

3.7

72

16.29

17.8 %

316.9

-13.55

-0.1 %

-263.6

0.94

18.3

0

-12.6

9.2 %

-245.1

0.1

1.9

-12.7

8.9 %

-247.08

-0.48

26.29

2023-03-31
%

1.22

-53.8 %

100

0.93

76.2

0.29

23.8

9.94

814.8

3.89

318.9

13.83

-2.6 %

1133.6

-13.54

-17.1 %

-1109.8

-0.33

-27.05

0

-13.87

7.1 %

-1136.9

0.07

5.7

-13.94

7.1 %

-1142.6

-0.53

26.29

2022-12-31
%

2.64

-82.7 %

100

0

0

10.49

397.3

3.71

140.5

14.2

-15.3 %

537.9

-11.56

-665.6 %

-437.9

-3.37

-127.7

0

-14.93

-1535.6 %

-565.5

0.07

2.7

-15

-1600 %

-568.2

-0.57

26.29

2022-09-30
%

15.26

3146.8 %

100

0

0

13.68

89.6

3.1

20.3

16.77

45.3 %

109.9

-1.51

86.4 %

-9.9

2.55

16.7

0

1.04

113 %

6.8

0.05

0.3

1

112.3 %

6.6

0.04

26.45

2022-06-30
%

0.47

-53.9 %

100

0

0

8.37

1780.9

3.17

674.5

11.54

-1.6 %

2455.3

-11.08

-3.5 %

-2357.4

3.05

648.9

0

-8.03

17.7 %

-1708.5

0.08

17

-8.11

17.4 %

-1725.5

-0.31

25.78

2022-03-31
%

1.02

-70.9 %

100

0

0

7.5

735.3

4.24

415.7

11.73

-36.3 %

1150

-10.71

28.2 %

-1050

0.95

93.1

0

-9.76

36.9 %

-956.9

0.06

5.9

-9.82

36.7 %

-962.7

-0.38

25.78

2020-12-31
%

3.5

438.5 %

100

0

0

15.7

448.6

2.72

77.7

18.42

127.1 %

526.3

-14.92

-100 %

-426.3

-0.54

-15.4

0

-15.46

-96.4 %

-441.7

0.04

1.1

-15.51

-97.1 %

-443.1

-0.61

25.35

2020-06-30
%

0.65

100

0

0

6.62

1018.5

1.49

229.2

8.11

1247.7

-7.46

-1147.7

-0.41

-63.08

0

-7.87

-1210.8

0

-7.87

-1210.8

-0.31

25.35

View Section: Balance Sheet